Report for: Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Title	Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol
Published in	International braz j urol, April 2004
DOI	10.1590/s1677-55382004000200007
Pubmed ID	15703094
Authors	Michael Mcdonald, Richard A. Santucci
Abstract	Low-flow priapism can result in impotence if treatment is delayed, yet patients with recurrent priapism often suffer delay before therapy. We describe management of recurrent priapism using self-administered injections of intracavernosal metaraminol (Aramine, Merck), a long-acting vasoconstricting amine that is considered safer than epinephrine. The patient injects as often as once daily using 5-10 mg of drug. Our patient reports rapid detumescence and has not required emergency room visits since starting injections. He denies complications. Treatment of priapism using metaraminol has been suggested in the hospital setting; however, this is the first report of successful home self-administration of the drug.

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Brazil	1	7%
Unknown	14	93%

Demographic breakdown

Readers by professional status	Count	As %
Student > Ph. D. Student	3	20%
Researcher	3	20%
Student > Master	2	13%
Student > Bachelor	2	13%
Student > Postgraduate	2	13%
Other	1	7%
Unknown	2	13%

Readers by discipline	Count	As %
Medicine and Dentistry	8	53%
Psychology	2	13%
Biochemistry, Genetics and Molecular Biology	1	7%
Computer Science	1	7%
Unknown	3	20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2019.

All research outputs

#1,120,612

of 4,655,094 outputs

Outputs from International braz j urol

of 137 outputs

Outputs of similar age

#47,545

of 161,159 outputs

Outputs of similar age from International braz j urol

of 1 outputs

Altmetric has tracked 4,655,094 research outputs across all sources so far. This one has received more attention than most of these and is in the 63rd percentile.

So far Altmetric has tracked 137 research outputs from this source. They receive a mean Attention Score of 0.8. This one has done particularly well, scoring higher than 97% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,159 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.

We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them

Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol

About this Attention Score

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context